Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of CRKL protein | decreases expression | 16483693
|
D017638 |
Asbestos, Crocidolite |
Asbestos, Crocidolite affects the expression of CRKL mRNA | affects expression | 17331233
|
D003907 |
Dexamethasone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CRKL mRNA | affects cotreatment|decreases expression | 16054899
|
C479799 |
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide |
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide results in decreased expression of CRKL mRNA | decreases expression | 15528975
|
D004958 |
Estradiol |
Estradiol affects the expression of CRKL mRNA | affects expression | 14699072
|
C097613 |
imatinib |
imatinib results in decreased phosphorylation of CRKL protein | decreases phosphorylation | 17432977
|
D015056 |
1-Methyl-3-isobutylxanthine |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CRKL mRNA | affects cotreatment|decreases expression | 16054899
|
C089730 |
rosiglitazone |
[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in decreased expression of CRKL mRNA | affects cotreatment|decreases expression | 16054899
|
D014212 |
Tretinoin |
[CRKL gene mutant form co-treated with TBX1 gene mutant form] affects the abundance of Tretinoin | affects abundance|affects cotreatment | 16399080
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000015 |
Abnormalities, Multiple |
|
imatinib |
5.46 | 18322153 |
MESH:D000022 |
Abortion, Spontaneous |
|
imatinib |
6.53 | 18322153 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.84 | 18287403 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
2.14 | 11473722 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.78 | 15955085 |
MESH:D000544 |
Alzheimer Disease |
|
rosiglitazone |
2.89 | 19621015 |
MESH:D001169 |
Arthritis, Experimental |
|
Dexamethasone |
7.92 | 17659584 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
7.92 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.30 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.39 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.64 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.81 | 16197459 16206674 |
MESH:D001859 |
Bone Neoplasms |
|
imatinib |
5.55 | 15867366 |
MESH:D001943 |
Breast Neoplasms |
|
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide |
2.14 | 15528975 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
2.14 | 17261762 19861407 16675129 17018787 14630087 18497071 12948864 17289903 |
MESH:D001943 |
Breast Neoplasms |
|
imatinib |
2.14 | 17614352 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.14 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.88 | 16813970 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.75 | 16111702 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.48 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
3.09 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.09 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
2.34 | 16051514 16096774 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.20 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
2.91 | 18566989 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.88 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.48 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.74 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.96 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Dexamethasone |
2.52 | 15824018 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Dexamethasone |
4.18 | 17728286 |
MESH:D019465 |
Craniofacial Abnormalities |
|
imatinib |
4.18 | 18322153 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
4.18 | 17551590 14991402 16925845 9664655 10589399 9211117 9125849 9142499 8800419 9224671 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Dexamethasone |
3.66 | 12438553 |
MESH:D003920 |
Diabetes Mellitus |
|
rosiglitazone |
4.48 | 17446233 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
rosiglitazone |
2.98 | 12642470 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.59 | 19279558 |
MESH:D003967 |
Diarrhea |
|
Dexamethasone |
3.93 | 7237001 |
MESH:D004062 |
DiGeorge Syndrome |
marker/mechanism |
|
| 16399080 |
MESH:D004485 |
Eczema |
|
Dexamethasone |
4.70 | 12438553 |
MESH:D004487 |
Edema |
|
Dexamethasone |
13.09 | 19703484 |
MESH:D004487 |
Edema |
|
imatinib |
13.09 | 19703484 |
MESH:D004487 |
Edema |
|
rosiglitazone |
13.09 | 12083418 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.78 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
7.84 | 11473722 19148513 18566989 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
7.84 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.73 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
rosiglitazone |
4.14 | 19196556 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
imatinib |
5.93 | 17453242 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.77 | 17994277 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.13 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.32 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.48 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
2.99 | 14991402 9664655 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Dexamethasone |
3.13 | 7520565 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
5.35 | 15709030 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
4.07 | 17088409 |
MESH:D006930 |
Hyperalgesia |
|
rosiglitazone |
8.62 | 12083418 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
8.62 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.83 | 16778211 |
MESH:D006973 |
Hypertension |
|
Dexamethasone |
3.00 | 17042910 |
MESH:D007077 |
Ileal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.76 | 18306037 |
MESH:D007249 |
Inflammation |
|
Dexamethasone |
5.87 | 8960868 11099482 |
MESH:D007249 |
Inflammation |
|
rosiglitazone |
5.87 | 12083418 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
8.05 | 16627594 16393666 |
MESH:D007333 |
Insulin Resistance |
|
rosiglitazone |
8.05 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.02 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.11 | 17551590 15992940 |
MESH:D007579 |
Jejunal Diseases |
|
1-Methyl-3-isobutylxanthine |
5.76 | 18306037 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
2.69 | 15618244 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
3.15 | 15610895 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.86 | 17143497 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
imatinib |
4.92 | 17301526 15107311 15748426 19208803 |
MESH:D007951 |
Leukemia, Myeloid |
|
imatinib |
10.66 | 17236224 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
10.66 | 16482212 19285840 16932348 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.10 | 19850784 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.28 | 17294898 16140955 17649720 17368321 19075265 9834237 17339181 17506722 16788101 12679006 17107899 15748426 16823087 17217047 19642359 16331271 19035177 16766008 19029980 17712046 19225113 16935935 17361223 16891316 17301526 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.45 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Dexamethasone |
7.02 | 16718785 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
7.02 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
imatinib |
7.02 | 16596278 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
rosiglitazone |
7.02 | 15980055 17347453 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
7.02 | 16248980 18397230 |
MESH:D055370 |
Lung Injury |
|
Asbestos, Crocidolite |
4.28 | 17365036 |
MESH:D008175 |
Lung Neoplasms |
|
Dexamethasone |
3.35 | 11195469 15824018 |
MESH:D008175 |
Lung Neoplasms |
|
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide |
3.35 | 15528975 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
6.67 | 11807958 11408345 17203775 16891317 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
rosiglitazone |
6.67 | 16827153 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.80 | 19453300 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.85 | 17453147 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
1.96 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.68 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Asbestos, Crocidolite |
3.25 | 18303189 16166281 16966607 |
MESH:D024821 |
Metabolic Syndrome X |
|
rosiglitazone |
4.55 | 17261469 |
MESH:D009101 |
Multiple Myeloma |
|
Dexamethasone |
3.65 | 15867202 16118317 15744524 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Dexamethasone |
7.90 | 9809623 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.90 | 17596541 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
3.44 | 16810080 |
MESH:D009362 |
Neoplasm Metastasis |
|
imatinib |
4.08 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
2.49 | 16594593 16946489 |
MESH:D009376 |
Neoplasms, Hormone-Dependent |
|
imatinib |
5.78 | 17614352 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
4.02 | 17289903 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
10.48 | 11399458 16427766 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
10.48 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
3.18 | 9142499 |
MESH:D010014 |
Osteolysis |
|
imatinib |
6.02 | 15867366 |
MESH:D010051 |
Ovarian Neoplasms |
|
(E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide |
8.43 | 15528975 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
8.43 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
8.43 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.07 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.52 | 15976015 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Crocidolite |
5.15 | 10923243 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Dexamethasone |
8.41 | 21297632 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
imatinib |
8.41 | 12476293 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
4.09 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
3.05 | 16740699 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.82 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.08 | 16723453 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Crocidolite |
3.09 | 17365031 15814490 17975199 17322281 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Dexamethasone |
4.24 | 18379247 11700416 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.32 | 16283617 16116481 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
2.69 | 16467112 |
MESH:D013272 |
Stomach Diseases |
|
Dexamethasone |
4.60 | 15472012 |
MESH:D013274 |
Stomach Neoplasms |
|
imatinib |
2.99 | 15786421 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.99 | 17261132 |
MESH:D013276 |
Stomach Ulcer |
|
Dexamethasone |
3.69 | 15138204 |
MESH:D013964 |
Thyroid Neoplasms |
|
imatinib |
8.22 | 16940797 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.22 | 16026305 17045167 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
5.00 | 19048282 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
3.98 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.34 | 16040207 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
3.87 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.93 | 16752155 |
MESH:D014605 |
Uveitis |
|
Dexamethasone |
5.13 | 1336536 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.29 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.15 | 16287080 |